News

The acquisition close follows the Letter of Intent executed on 22 December 2010, and the SPA announced on 23 February 2011. As previously reported, the consideration for the

Matrix Laboratories, a subsidiary of Mylan, claims Gabapentin capsules USP are the genereic version of Pfizer’s treatment for painful complication of shingles, Neurontin capsules. Gabapentin capsule is an

According to the company, the new application will help the researchers in improving accuracy while assessing drug safety and effectiveness, testing for drug interactions and developing new drugs.

The patent titled ‘Healthcare information management and communications system and method,’ application makes 104 separate claims. With the filing of the full utility patent, InstaCare plans to immediately

Leo Pharma has already executed installing Veeva CRM to its users in countries such as Hungary, Czech Republic, Slovakia, Poland, Romania, and Italy. Veeva Europe general manager Dan

Thermo Fisher Scientific vice president and general manager Verner Andersen said the acquisition of BD’s assets enables the company to provide continued availability of the product line to

Marketing head Jim Greaves said the RUO system launch is a truly transformative technology introduction, in advance of our fully regulated RenDx platform for human diagnostics that is

Istodax is indicated for treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy. Celgene said that sNDA filing for Istodax

The new patent covers several new quinoxalinyl-piperazine compounds, the process for their preparation, pharmaceutical composition, and a method for their producing an anti-proliferative effect. Additionally, the new patent